aluates Reports

$ 0.0

Automative

Global NASH Therapeutic Drugs Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-13O13699

Global NASH Therapeutic Drugs Market Research Report 2023

BUY CHAPTERS

Global NASH Therapeutic Drugs Market Research Report 2024

Code: QYRE-Auto-13O13699

Report

January 2024

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

NASH Therapeutic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

NASH Therapeutic Drugs Market

The global NASH Therapeutic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for NASH Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NASH Therapeutic Drugs.

Report Scope

The NASH Therapeutic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NASH Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NASH Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NASH Therapeutic Drugs Market Report

Report Metric	Details
Report Name	NASH Therapeutic Drugs Market
CAGR	5%
Segment by Type	Vitamin E and Pioglitazone Ocaliva Elafibranor Selonsertib and Cenicriviroc
Segment by Application	Hospital Pharmacy Online Provider Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Zydus Cadila
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NASH Therapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the NASH Therapeutic Drugs Market report?

Ans: The main players in the NASH Therapeutic Drugs Market are Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Zydus Cadila

What are the Application segmentation covered in the NASH Therapeutic Drugs Market report?

Ans: The Applications covered in the NASH Therapeutic Drugs Market report are Hospital Pharmacy, Online Provider, Retail Pharmacy

What are the Type segmentation covered in the NASH Therapeutic Drugs Market report?

Ans: The Types covered in the NASH Therapeutic Drugs Market report are Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Vitamin E and Pioglitazone

1.2.3 Ocaliva

1.2.4 Elafibranor

1.2.5 Selonsertib and Cenicriviroc

1.3 Market by Application

1.3.1 Global NASH Therapeutic Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Online Provider

1.3.4 Retail Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NASH Therapeutic Drugs Market Perspective (2019-2030)

2.2 NASH Therapeutic Drugs Growth Trends by Region

2.2.1 Global NASH Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NASH Therapeutic Drugs Historic Market Size by Region (2019-2024)

2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Region (2025-2030)

2.3 NASH Therapeutic Drugs Market Dynamics

2.3.1 NASH Therapeutic Drugs Industry Trends

2.3.2 NASH Therapeutic Drugs Market Drivers

2.3.3 NASH Therapeutic Drugs Market Challenges

2.3.4 NASH Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NASH Therapeutic Drugs Players by Revenue

3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2019-2024)

3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2019-2024)

3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue

3.4 Global NASH Therapeutic Drugs Market Concentration Ratio

3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2023

3.5 NASH Therapeutic Drugs Key Players Head office and Area Served

3.6 Key Players NASH Therapeutic Drugs Product Solution and Service

3.7 Date of Enter into NASH Therapeutic Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NASH Therapeutic Drugs Breakdown Data by Type

4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2019-2024)

4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2025-2030)

5 NASH Therapeutic Drugs Breakdown Data by Application

5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2019-2024)

5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NASH Therapeutic Drugs Market Size (2019-2030)

6.2 North America NASH Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NASH Therapeutic Drugs Market Size by Country (2019-2024)

6.4 North America NASH Therapeutic Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NASH Therapeutic Drugs Market Size (2019-2030)

7.2 Europe NASH Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NASH Therapeutic Drugs Market Size by Country (2019-2024)

7.4 Europe NASH Therapeutic Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2019-2030)

8.2 Asia-Pacific NASH Therapeutic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NASH Therapeutic Drugs Market Size (2019-2030)

9.2 Latin America NASH Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NASH Therapeutic Drugs Market Size by Country (2019-2024)

9.4 Latin America NASH Therapeutic Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2019-2030)

10.2 Middle East & Africa NASH Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan Plc (Tobira)

11.1.1 Allergan Plc (Tobira) Company Detail

11.1.2 Allergan Plc (Tobira) Business Overview

11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction

11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.1.5 Allergan Plc (Tobira) Recent Development

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Detail

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction

11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.2.5 Bristol Myers Squibb Recent Development

11.3 Galmed Pharmaceuticals

11.3.1 Galmed Pharmaceuticals Company Detail

11.3.2 Galmed Pharmaceuticals Business Overview

11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction

11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.3.5 Galmed Pharmaceuticals Recent Development

11.4 Genfit SA

11.4.1 Genfit SA Company Detail

11.4.2 Genfit SA Business Overview

11.4.3 Genfit SA NASH Therapeutic Drugs Introduction

11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.4.5 Genfit SA Recent Development

11.5 Gilead Sciences, Inc.

11.5.1 Gilead Sciences, Inc. Company Detail

11.5.2 Gilead Sciences, Inc. Business Overview

11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction

11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.5.5 Gilead Sciences, Inc. Recent Development

11.6 Intercept Pharmaceuticals, Inc.

11.6.1 Intercept Pharmaceuticals, Inc. Company Detail

11.6.2 Intercept Pharmaceuticals, Inc. Business Overview

11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction

11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.6.5 Intercept Pharmaceuticals, Inc. Recent Development

11.7 Zydus Cadila

11.7.1 Zydus Cadila Company Detail

11.7.2 Zydus Cadila Business Overview

11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction

11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2019-2024)

11.7.5 Zydus Cadila Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol–Myers Squibb

Galmed Pharmaceuticals

Genfit SA

Gilead Sciences Inc

Intercept Pharmaceuticals Inc

Zydus Cadila

List of Tables

Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Vitamin E and Pioglitazone

Table 3. Key Players of Ocaliva

Table 4. Key Players of Elafibranor

Table 5. Key Players of Selonsertib and Cenicriviroc

Table 6. Global NASH Therapeutic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global NASH Therapeutic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global NASH Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global NASH Therapeutic Drugs Market Share by Region (2019-2024)

Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global NASH Therapeutic Drugs Market Share by Region (2025-2030)

Table 12. NASH Therapeutic Drugs Market Trends

Table 13. NASH Therapeutic Drugs Market Drivers

Table 14. NASH Therapeutic Drugs Market Challenges

Table 15. NASH Therapeutic Drugs Market Restraints

Table 16. Global NASH Therapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global NASH Therapeutic Drugs Market Share by Players (2019-2024)

Table 18. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2023)

Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service

Table 23. Date of Enter into NASH Therapeutic Drugs Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NASH Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global NASH Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global NASH Therapeutic Drugs Revenue Market Share by Application (2019-2024)

Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global NASH Therapeutic Drugs Revenue Market Share by Application (2025-2030)

Table 33. North America NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific NASH Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa NASH Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 48. Allergan Plc (Tobira) Company Detail

Table 49. Allergan Plc (Tobira) Business Overview

Table 50. Allergan Plc (Tobira) NASH Therapeutic Drugs Product

Table 51. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 52. Allergan Plc (Tobira) Recent Development

Table 53. Bristol Myers Squibb Company Detail

Table 54. Bristol Myers Squibb Business Overview

Table 55. Bristol Myers Squibb NASH Therapeutic Drugs Product

Table 56. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 57. Bristol Myers Squibb Recent Development

Table 58. Galmed Pharmaceuticals Company Detail

Table 59. Galmed Pharmaceuticals Business Overview

Table 60. Galmed Pharmaceuticals NASH Therapeutic Drugs Product

Table 61. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 62. Galmed Pharmaceuticals Recent Development

Table 63. Genfit SA Company Detail

Table 64. Genfit SA Business Overview

Table 65. Genfit SA NASH Therapeutic Drugs Product

Table 66. Genfit SA Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 67. Genfit SA Recent Development

Table 68. Gilead Sciences, Inc. Company Detail

Table 69. Gilead Sciences, Inc. Business Overview

Table 70. Gilead Sciences, Inc. NASH Therapeutic Drugs Product

Table 71. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 72. Gilead Sciences, Inc. Recent Development

Table 73. Intercept Pharmaceuticals, Inc. Company Detail

Table 74. Intercept Pharmaceuticals, Inc. Business Overview

Table 75. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product

Table 76. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 77. Intercept Pharmaceuticals, Inc. Recent Development

Table 78. Zydus Cadila Company Detail

Table 79. Zydus Cadila Business Overview

Table 80. Zydus Cadila NASH Therapeutic Drugs Product

Table 81. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2019-2024) & (US$ Million)

Table 82. Zydus Cadila Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NASH Therapeutic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global NASH Therapeutic Drugs Market Share by Type: 2023 VS 2030

Figure 3. Vitamin E and Pioglitazone Features

Figure 4. Ocaliva Features

Figure 5. Elafibranor Features

Figure 6. Selonsertib and Cenicriviroc Features

Figure 7. Global NASH Therapeutic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global NASH Therapeutic Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacy Case Studies

Figure 10. Online Provider Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. NASH Therapeutic Drugs Report Years Considered

Figure 13. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global NASH Therapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global NASH Therapeutic Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global NASH Therapeutic Drugs Market Share by Players in 2023

Figure 17. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NASH Therapeutic Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2023

Figure 19. North America NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 21. United States NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 25. Germany NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific NASH Therapeutic Drugs Market Share by Region (2019-2030)

Figure 33. China NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 41. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa NASH Therapeutic Drugs Market Share by Country (2019-2030)

Figure 45. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 48. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 49. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 50. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 51. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 52. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 53. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions